• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然糖衍生生物材料用于炎症靶向药物递送。

Natural Glycan Derived Biomaterials for Inflammation Targeted Drug Delivery.

机构信息

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.

出版信息

Macromol Biosci. 2021 Sep;21(9):e2100162. doi: 10.1002/mabi.202100162. Epub 2021 Jun 18.

DOI:10.1002/mabi.202100162
PMID:34145960
Abstract

Inflammation is closely related to a variety of fatal or chronic diseases. Hence, targeting inflammation provides an alternative approach to improve the therapeutic outcome of diseases such as solid tumors, neurological diseases, and metabolic diseases. Polysaccharides are natural components with immune regulation, anti-virus, anti-cancer, anti-inflammation, and anti-oxidation activities. Herein, this review highlights recent progress in the polysaccharide-based drug delivery systems for achieving inflammation targeting and its related disease treatment. Moreover, the chemical modification and the construction of polysaccharide materials for drug delivery are discussed in detail.

摘要

炎症与多种致命或慢性疾病密切相关。因此,针对炎症提供了一种改善实体瘤、神经退行性疾病和代谢性疾病等疾病治疗效果的替代方法。多糖是具有免疫调节、抗病毒、抗癌、抗炎和抗氧化作用的天然成分。本文重点介绍了基于多糖的药物传递系统在实现炎症靶向及其相关疾病治疗方面的最新进展。此外,还详细讨论了用于药物传递的多糖材料的化学修饰和构建。

相似文献

1
Natural Glycan Derived Biomaterials for Inflammation Targeted Drug Delivery.天然糖衍生生物材料用于炎症靶向药物递送。
Macromol Biosci. 2021 Sep;21(9):e2100162. doi: 10.1002/mabi.202100162. Epub 2021 Jun 18.
2
Recent advances in plant polysaccharide-mediated nano drug delivery systems.植物多糖介导的纳米药物传递系统的最新进展。
Int J Biol Macromol. 2020 Dec 15;165(Pt B):2668-2683. doi: 10.1016/j.ijbiomac.2020.10.173. Epub 2020 Oct 25.
3
Marine polysaccharide-based nanomaterials as a novel source of nanobiotechnological applications.基于海洋多糖的纳米材料作为纳米生物技术应用的新型来源。
Int J Biol Macromol. 2016 Jan;82:315-27. doi: 10.1016/j.ijbiomac.2015.10.081. Epub 2015 Oct 30.
4
Polysaccharide Nanoparticles for Targeted Cancer Therapies.用于靶向癌症治疗的多糖纳米颗粒
Curr Drug Metab. 2018;19(9):781-792. doi: 10.2174/1389200219666180511153403.
5
Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.基于碳水化合物的聚合物的抗癌药物传递。
Curr Pharm Des. 2018 Feb 12;23(39):6019-6032. doi: 10.2174/1381612823666170505124927.
6
[Progress in application of Bletilla striata polysaccharide in novel drug delivery systems and biomaterials].白及多糖在新型药物递送系统和生物材料中的应用进展
Zhongguo Zhong Yao Za Zhi. 2021 Sep;46(18):4666-4673. doi: 10.19540/j.cnki.cjcmm.20210528.604.
7
Role of Polysaccharides Mimetic Components in Targeted Cancer Treatment.多糖模拟物成分在靶向癌症治疗中的作用。
Curr Drug Targets. 2022;23(9):856-868. doi: 10.2174/1389450123666220214121505.
8
The choice of anti-tumor strategies based on micromolecules or drug loading function of biomaterials.基于小分子的抗肿瘤策略选择或生物材料的载药功能。
Cancer Lett. 2020 Sep 1;487:45-52. doi: 10.1016/j.canlet.2020.05.019. Epub 2020 May 29.
9
Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment.生物材料作为治疗炎症性肠病的治疗药物载体。
J Control Release. 2022 May;345:1-19. doi: 10.1016/j.jconrel.2022.02.028. Epub 2022 Feb 25.
10
Agarose-based biomaterials for advanced drug delivery.基于琼脂糖的生物材料在高级药物输送中的应用。
J Control Release. 2020 Oct 10;326:523-543. doi: 10.1016/j.jconrel.2020.07.028. Epub 2020 Jul 20.

引用本文的文献

1
Advances in biomaterials for oral-maxillofacial bone regeneration: spotlight on periodontal and alveolar bone strategies.口腔颌面骨再生生物材料的进展:聚焦牙周和牙槽骨策略
Regen Biomater. 2024 Jul 4;11:rbae078. doi: 10.1093/rb/rbae078. eCollection 2024.
2
Pathological mechanism of immune disorders in diabetic kidney disease and intervention strategies.糖尿病肾病免疫紊乱的病理机制及干预策略。
World J Diabetes. 2024 Jun 15;15(6):1111-1121. doi: 10.4239/wjd.v15.i6.1111.